Peptide Libraray

Not available

General Information

DCTPep ID DCTPep01162

Peptide Name Not available

Sequence TEATITGLEPGTEYTITVIAL

Sequence Length 21

UniProt ID Not available

PubChem CID Not available

Origin Not available

Type Synthetic peptide

Classification

ACP

Activity Information

Hemolytic Activity Not available

Normal (non-cancerous) Cytotoxicity Not available

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure DCTPep01162

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Free

Other Modification None

Chiral L

Physicochemical Information

Formula C98H161N21O35

Absent amino acids CDFHKMNQRSW

Theoretical pI 3.67

Acidic residues 3

Basic residues 0

Polar residues 9

Molecular weight (Average) 2193.48

Molecular weight (Monoisotopic) 2192.15

Common amino acids T

Net charge -3

Instability index (II) 24.91

Aliphatic index 116.19

Grand average of hydropathicity (GRAVY) 0.500

Half Life
7.2 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 0.679

Amino acid distribution

Literature Information

Literature 1

Pubmed ID Not available

Title Not available

Doi Not available

Year Not available

Patent

Patent ID EP2716297B1

Patent Title D-Glu-Fniii14 Polypeptide for Use in Treating Cancer

Other Iinformation Granted Patent; Family: 8s / 8ex; Family Jurisdictions: JP, WO, US, EP; Legal Status: Active; Application No: 12758028; Filed: Mar 9, 2012; Published: Sep 27, 2017; Earliest Priority: Mar 11, 2011; Granted: Sep 27, 2017

Other Published ID EP2716297A4 EP2716297B1 JP5924593B2 JPWO2012124641A1 US2014005120A1 US9327013B2 WO2012124641A1